13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
Live feed/ Filings/ SCHEDULE/ 0001415889-25-008276
SCHEDULE Filed 2025-03-17 Event 2025-03-13 SEC 0001415889-25-008276 →

Samsara BioCapital, L.P. → Mineralys Therapeutics, Inc. MLYS

Stake: 9.10% Shares: 5,736,305 CUSIP: 603170101 Class: Common Stock

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
23 transactions
0 buys · 11 sales · 12 awards/exercises
Issuer Cluster
2 13D/G filings on this issuer
1 other filing besides this one
Filer Track Record
7 filings by this filer
6 other filings in the data moat
Short Interest · settle 2026-07-15
DTC 9.78
9,552,513 shares short · -13.9% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers
1 holder · $43.81M
Point72 Asset Mgmt

Post-Filing Returns · since 2025-03-13 on MLYS

+1 day
0.0%
+5 days
0.0%
+30 days
0.0%
+60 days
0.0%
+90 days
0.0%
+180 days
0.0%

Anchor price 30.46 on closest trading day on/after 2025-03-13. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Form 4 Insider Transactions · last 365d

DateInsiderRoleTypeSharesPriceValue
2026-07-15 Rodman David Malcom officer Sale 6,349 $26.61 $169K
2026-07-13 Congleton Jon director, officer Sale 10,700 $27.24 $291K
2026-07-13 Rodman David Malcom officer Option exercise 3,542 $10.20 $36K
2026-07-13 Rodman David Malcom officer Option exercise 4,167 $14.25 $59K
2026-07-13 Rodman David Malcom officer Option exercise 6,349 $1.08 $7K
2026-07-13 Rodman David Malcom officer Sale 14,058 $27.58 $388K
2026-07-09 Rodman David Malcom officer Option exercise 2,171 $16.00 $35K
2026-07-09 Rodman David Malcom officer Sale 2,171 $30.30 $66K
2026-06-17 Rodman David Malcom officer Option exercise 4,167 $14.25 $59K
2026-06-17 Rodman David Malcom officer Option exercise 417 $15.44 $6K
2026-06-17 Rodman David Malcom officer Sale 4,584 $25.00 $115K
2026-06-17 Karydas Daphne director Option exercise 3,000 $12.02 $36K
2026-06-17 Karydas Daphne director Sale 3,000 $25.00 $75K
2026-06-15 Rodman David Malcom officer Option exercise 3,542 $10.20 $36K
2026-06-15 Rodman David Malcom officer Sale 9,890 $23.81 $235K
2026-04-15 Rodman David Malcom officer Sale 6,348 $27.66 $176K
2026-04-13 Congleton Jon director, officer Sale 15,730 $26.83 $422K
2026-04-13 Rodman David Malcom officer Option exercise 6,349 $1.08 $7K
2026-04-13 Rodman David Malcom officer Option exercise 3,542 $10.20 $36K
2026-04-13 Rodman David Malcom officer Option exercise 4,167 $14.25 $59K
2026-04-13 Rodman David Malcom officer Sale 14,058 $26.54 $373K
2026-04-09 Rodman David Malcom officer Option exercise 2,170 $16.00 $35K
2026-04-09 Rodman David Malcom officer Sale 2,170 $27.38 $59K

Other 13D/G Filings on Mineralys Therapeutics, Inc.

FiledFormFilerStakeShares
2025-03-17 SCHEDULE RA CAPITAL MANAGEMENT, L.P. 9.90% 6,287,597 view →

Other Filings by Samsara BioCapital, L.P.

FiledFormIssuerStakeShares
2026-05-28 SCHEDULE 13D/A RANI THERAPEUTICS HOLDINGS, INC. RANI — 5,661,481 view →
2026-05-22 SCHEDULE 13D/A KALARIS THERAPEUTICS, INC. KLRS 54.20% 10,657,028 view →
2026-01-13 SCHEDULE ALUMIS INC. ALMS 5.40% 6,345,219 view →
2025-11-24 SCHEDULE Nkarta, Inc. NKTX 4.90% 3,507,666 view →
2025-09-03 SCHEDULE vTv Therapeutics Inc. VTVT 9.90% 343,223 view →
2024-10-07 SC Scholar Rock Holding Corp SRRK — — view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →